Gaps in the ethical governance of pharmaceutical clinical trials in Europe
The ethical governance of pharmaceutical clinical trials in Europe, particularly under Regulation 536/2014, is intended to ensure the safety, rights, and well-being of participants.Despite this regulatory framework, significant gaps in ethical oversight remain.This paper identifies five key deficiencies: (1) European regulations only partially addr